Yiviva is dedicated to enhancing longevity by developing multi-targeted medicines that prevent, treat, and cure complex, aging-associated diseases such as cancer, chronic diseases, and inflammatory conditions. The company employs a sophisticated approach that views and treats the entire person as a system, aiming to improve overall patient outcomes. Yiviva's market focus includes next-generation cancer treatments and other advanced therapeutic solutions.
Yiviva has made significant strides in the field of systems biology medicines, leveraging natural compounds to create innovative treatments. One of its notable achievements is the development of a first-in-class platform cancer drug that functions as an immunomodulator within the tumor microenvironment. This breakthrough underscores Yiviva's commitment to pioneering new frontiers in medical science and improving the quality of life for patients worldwide.
